Phytoestrogen Supplements for the Treatment of Hot Flashes: The Isoflavone Clover Extract (ICE) Study: A Randomized Controlled Trial

JAMA

Volumn 290, Issue 2, 2003, Pages 207-214

  Tice, Jeffrey A ^a,c   Ettinger, Bruce ^f   Ensrud, Kris ^d,e   Wallace, Robert ^g   Blackwell, Terri ^b,c   Cummings, Steven R ^b,c  

^a UNIVERSITY OF CALIFORNIA   (United States)

^b UNIVERSITY OF CALIFORNIA   (United States)

^c UNIVERSITY OF CALIFORNIA   (United States)

^d UNIVERSITY OF MINNESOTA   (United States)

^e VETERANS AFFAIRS MEDICAL CENTER   (United States)

^f DIVISION OF RESEARCH   (United States)

^g UNIVERSITY OF IOWA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BIOCHANIN A; DAIDZEIN; ESTROGEN RECEPTOR ALPHA; ESTROGEN RECEPTOR BETA; FORMONONETIN; GENISTEIN; ISOFLAVONE CLOVER EXTRACT; ISOFLAVONE DERIVATIVE; PHYTOESTROGEN; PLACEBO; PLANT EXTRACT; UNCLASSIFIED DRUG; ESTROGEN; PLANT MEDICINAL PRODUCT;

ADULT; ARTHRALGIA; ARTICLE; BLOOD PRESSURE; BREAST CANCER; CARDIOVASCULAR RISK; CLINICAL RESEARCH; CLINICAL TRIAL; CLOVER; COMMON COLD; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DIARRHEA; DIET SUPPLEMENTATION; DOSE TIME EFFECT RELATION; DOUBLE BLIND PROCEDURE; DRUG EFFICACY; DRUG SAFETY; FEMALE; FOLLOW UP; FRACTURE; GALLBLADDER DISEASE; HEADACHE; HEART INFARCTION; HEART RATE; HORMONE SUBSTITUTION; HOT FLUSH; HUMAN; LUNG EMBOLISM; MAJOR CLINICAL STUDY; MASTALGIA; MENOPAUSE; MULTICENTER STUDY; MYALGIA; NAUSEA; PRIORITY JOURNAL; QUALITY OF LIFE; RANDOMIZED CONTROLLED TRIAL; RED CLOVER; SIDE EFFECT; SOYBEAN; SPOTTING; STROKE; SYMPTOMATOLOGY; UPPER RESPIRATORY TRACT INFECTION; VAGINA BLEEDING; VEGETARIAN; VEIN THROMBOSIS; COMPARATIVE STUDY; DRUG EFFECT; MIDDLE AGED; POSTMENOPAUSE;

DIETARY SUPPLEMENTS; DOUBLE-BLIND METHOD; ESTROGENS, NON-STEROIDAL; FEMALE; HOT FLASHES; HUMANS; ISOFLAVONES; MENOPAUSE; MIDDLE AGED; PHYTOESTROGENS; PLANT EXTRACTS; PLANT PREPARATIONS; POSTMENOPAUSE; QUALITY OF LIFE; TRIFOLIUM;

EID: 0038013919     PISSN: 00987484     EISSN: None     Source Type: Journal    
DOI: 10.1001/jama.290.2.207     Document Type: Article

References (51)

1. Writing Group for the Women's Health Initiative Investigators. Risks and benefits of estrogen plus progestin in healthy postmenopausal women: principal results from the Women's Health Initiative randomized controlled trial. JAMA. 2002;288:321-333.
2. Grady D, Herrington D, Bittner V, et al, for the HERS Research Group. Cardiovascular disease outcomes during 6.8 years of hormone therapy: Heart and Estrogen/progestin Replacement Study follow-up (HERS II). JAMA. 2002;288:49-57.
3. Hulley S, Furberg C, Barrett-Connor E, et al, for the HERS Research Group. Noncardiovascular disease outcomes during 6.8 years of hormone therapy: Heart and Estrogen/progestin Replacement Study follow-up (HERS II). JAMA. 2002;288:58-66.
4. Lock M. Contested meanings of the menopause. Lancet. 1991;337:1270-1272.
5. Lock M. Menopause in cultural context. Exp Gerontol. 1994;29:307-317.
6. Boulet MJ, Oddens BJ, Lehert P, Verner HM, Visser A. Climacteric and menopause in seven Southeast Asian countries. Maturitas. 1994;19:157-176.
7. Tang GW. The climacteric of Chinese factory workers. Maturitas. 1994;19:177-182.
8. Adlercreutz H. Western diet and Western diseases: some hormonal and biochemical mechanisms and associations. Scand J Clin Lab Invest Suppl. 1990;201:3-23.
9. Martin PM, Horwitz KB, Ryan DS, McGuire WL. Phytoestrogen interaction with estrogen receptors in human breast cancer cells. Endocrinology. 1978;103:1860-1867.
10. Kuiper GG, Carlsson B, Grandien K, et al. Comparison of the ligand binding specificity and transcript tissue distribution of estrogen receptors alpha and beta. Endocrinology. 1997;138:863-870.
11. Collins BM, McLachlan JA, Arnold SF. The estrogenic and antiestrogenic activities of phytochemicals with the human estrogen receptor expressed in yeast. Steroids. 1997;62:365-372.
12. Hall JM, McDonnell DP. The estrogen receptor beta-isoform (ERbeta) of the human estrogen receptor modulates ERalpha transcriptional activity and is a key regulator of the cellular response to estrogens and antiestrogens. Endocrinology. 1999;140:5566-5578.
13. The mainstreaming of alternative medicine. Consumer Reports. 2000;65:17.
14. Harris PF, Remington PL, Trentham-Dietz A, Allen CI, Newcomb PA. Prevalence and treatment of menopausal symptoms among breast cancer survivors. J Pain Symptom Manage. 2002;23:501-509.
15. Kam IW, Dennehy CE, Tsourounis C. Dietary supplement use among menopausal women attending a San Francisco health conference. Menopause. 2002;9:72-78.
16. White JP, Schilling JS. Postmenopausal hormone replacement: historical perspectives and current concerns. Clin Excell Nurse Pract. 2000;4:277-285.
17. Murkies AL, Lombard C, Strauss BJ, Wilcox G, Burger HG, Morton MS. Dietary flour supplementation decreases post-menopausal hot flushes: effect of soy and wheat. Maturitas. 1995;21:189-195.
18. Brzezinski A, Adlercreutz H, Shaoul R, et al. Short-term effects of phytoestrogen-rich diet on postmenopausal women. Menopause. 1997;4:89-94.
19. Albertazzi P, Pansini F, Bonaccorsi G, Zanotti L, Forini E, De Aloysio D. The effect of dietary soy supplementation on hot flushes. Obstet Gynecol. 1998;91:6-11.
20. Dalais FS, Rice GE, Wahlqvist ML, et al. Effects of dietary phytoestrogens in postmenopausal women. Climacteric. 1998;1:124-129.
21. Washburn S, Burke GL, Morgan T, Anthony M. Effect of soy protein supplementation on serum lipoproteins, blood pressure, and menopausal symptoms in perimenopausal women. Menopause. 1999;6:7-13.
22. Kotsopoulos D, Dalais FS, Liang YL, McGrath BP, Teede HJ. The effects of soy protein containing phytoestrogens on menopausal symptoms in postmenopausal women. Climacteric. 2000;3:161-167.
23. Quella SK, Loprinzi CL, Barton DL, et al. Evaluation of soy phytoestrogens for the treatment of hot flashes in breast cancer survivors: a North Central Cancer Treatment Group Trial. J Clin Oncol. 2000;18:1068-1074.
24. Scambia G, Mango D, Signorile PG, et al. Clinical effects of a standardized soy extract in postmenopausal women: a pilot study. Menopause. 2000;7:105-111.
25. Upmalis DH, Lobo R, Bradley L, Warren M, Cone FL, Lamia CA. Vasomotor symptom relief by soy isoflavone extract tablets in postmenopausal women: a multicenter, double-blind, randomized, placebo-controlled study. Menopause. 2000;7:236-242.
26. St Germain A, Peterson CT, Robinson JG, Alekel DL. Isoflavone-rich orisoflavone-poor soy protein does not reduce menopausal symptoms during 24 weeks of treatment. Menopause. 2001;8:17-26.
27. Knight DC, Howes JB, Eden JA, Howes LG. Effects on menopausal symptoms and acceptability of isoflavone-containing soy powder dietary supplementation. Climacteric. 2001;4:13-18.
28. Van Patten CL, Olivatta IA, Chambers GK, et al. Effect of soy phytoestrogens on hot flashes in postmenopausal women with breast cancer: a randomized, controlled clinical trial. J Clin Oncol. 2002;20:1449-1455.
29. Baber RJ, Templeman C, Moreton T, Kelly GE, West L. Randomized placebo-controlled trial of an isoflavone supplement and menopausal symptoms in women. Climacteric. 1999;2:85-92.
30. Knight DC, Howes JB, Eden JA. The effect of Promensil, an isoflavone extract, on menopausal symptoms. Climacteric. 1999;2:79-84.
31. Nachtigall L, Fenichel R, La Grega L, et al. The effects of isoflavone derived from red clover on vasomotor symptom, enodmetrial thickness, and reproductive hormone concentrations in menopausal women. Paper presented at: Proceedings of the 81st Annual Meeting of the Endocrine Society; June 12-15, 1999; San Diego, Calif.
32. Jeri A. The use of an isoflavone supplement to relieve hot flushes. Female Patient. 2002;27:35-37.
33. van de Weijer P, Barentsen R. Isoflavones from red clover (Promensil) significantly reduce menopausal hot flush symptoms compared with placebo. Maturitas. 2002;42:187.
34. Sloan JA, Loprinzi CL, Novotny PJ, Barton DL, Lavasseur BI, Windschitl H. Methodologic lessons learned from hot flash studies. J Clin Oncol. 2001;19:4280-4290.
35. Greene J. Constructing a standard climacteric scale. Maturitas. 1998;29:25-31.
36. Barentsen R, van de Weijer PH, van Gend S, Foekema H. Climacteric symptoms in a representative Dutch population sample as measured with the Greene Climacteric Scale. Maturitas. 2001;38:123-128.
37. Han KK, Soares JM Jr, Haidar MA, de Lima GR, Baracat EC. Benefits of soy isoflavone therapeutic regimen on menopausal symptoms. Obstet Gynecol. 2002;99:389-394.
38. King RA, Bursill DB. Plasma and urinary kinetics of the isoflavones daidzein and genistein after a single soy meal in humans. Am J Clin Nutr. 1998;67:867-872.
39. Watanabe S, Yamaguchi M, Sobue T, et al. Pharmacokinetics of soybean isoflavones in plasma, urine and feces of men after ingestion of 60 g baked soybean powder (kinako). J Nutr. 1998;128:1710-1715.
40. Setchell KD, Brown NM, Desai P, et al. Bioavailability of pure isoflavones in healthy humans and analysis of commercial soy isoflavone supplements. J Nutr. 2001;131(4 suppl):1362S-1375S.
41. MacLennan A, Lester S, Moore V. Oral estrogen replacement therapy versus placebo for hot flashes: a systematic review. Climacteric. 2001;4:58-74.
42. Xu X, Duncan AM, Merz BE, Kurzer MS. Effects of soy isoflavones on estrogen and phytoestrogen metabolism in premenopausal women. Cancer Epidemiol Biomarkers Prev. 1998;7:1101-1108.
43. Fritz WA, Wang J, Eltoum JE, Lamartiniere CA. Dietary genistein down-regulates androgen and estrogen receptor expression in the rat prostate. Mol Cell Endocrinol. 2002;186:89-99.
44. Tham DM, Gardner CD, Haskell WL. Clinical review 97: potential health benefits of dietary phytoestrogens: a review of the clinical, epidemiological, and mechanistic evidence. J Clin Endocrinol Metab. 1998;83:2223-2235.
45. Barnes S, Kirk M, Coward L. Isoflavones and their conjugates in soy foods: extraction conditions and analysis by HPLC-mass spectrometry. J Agric Food Chem. 1994;42:2466-2474.
46. Murphy PA. Phytoestrogen content of processed soybean products. Food Technol. 1982;34:60-64.
47. Erlik Y, Meldrum DR, Judd HL. Estrogen levels in postmenopausal women with hot flashes. Obstet Gynecol. 1982;59:403-407.
48. Hutton JD, Jacobs HS, Murray MA, James VH. Relation between plasma oestrone and oestradiol and climacteric symptoms. Lancet. 1978;1:678-681.
49. Gold EB, Sternfeld B, Kelsey JL, et al. Relation of demographic and lifestyle factors to symptoms in a multi-racial/ethnic population of women 40-55 years of age. Am J Epidemiol. 2000;152:463-473.
50. Whiteman MK, Staropoli CA, Langenberg PW, McCarter RJ, Kjerulff KH, Flaws JA. Smoking, body mass, and hot flashes in midlife women. Obstet Gynecol. 2003;101:264-272.
51. Freedman RR. Hot flash trends and mechanisms. Menopause. 2002;9:151-152.